IDiyas

For the Inventor, By the Inventor

Snohomish, WA, United States of America

Neil S Cutshall

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 71(Granted Patents)


Company Filing History:

goldMedal21 out of 97 
 
Omeros Corporation
 patents

Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):
1. 12195427 - MASP-2 inhibitors and methods of use (2025-01-14),
2. 12110288 - MASP-2 inhibitors and methods of use (2024-10-08),
3. 12030853 - MASP-2 inhibitors and methods of use (2024-07-09),
4. 11807641 - MASP-2 inhibitors and methods of use (2023-11-07),
5. 11661418 - MASP-2 inhibitors and methods of use (2023-05-30),
6. 11584714 - MASP-2 inhibitors and methods of use (2023-02-21),
7. 10106516 - PDE10 inhibitors and related compositions and methods (2018-10-23),
8. 9920045 - Solid state forms of a PDE10 inhibitor (2018-03-20),
9. 9850238 - Optically active PDE10 inhibitor (2017-12-26),
10. 9783521 - PDE10 inhibitors and related compositions and methods (2017-10-10),
11. 9650368 - Processes and intermediates for the preparation of a PDE10 inhibitor (2017-05-16),
12. 9493447 - Optically active PDE10 inhibitor (2016-11-15),
13. 9434707 - PDE10 inhibitors and related compositions and methods (2016-09-06),
14. 9119822 - Use of PDE7 inhibitors for the treatment of movement disorders (2015-09-01),
15. 9102643 - PDE10 inhibitors and related compositions and methods (2015-08-11),

Title: Neil S. Cutshall: Innovator in MASP-2 Inhibitors

Introduction: Neil S. Cutshall is a notable inventor based in Snohomish, Washington. He has made significant contributions to the field of biomedical innovation, with a strong focus on developing MASP-2 inhibitors. With a total of 21 patents under his name, Cutshall is recognized for his advancements and expertise in therapeutic compounds.

Latest Patents: Among Cutshall's most recent patents are his disclosures on MASP-2 inhibitors and methods of use. These patents detail compounds with MASP-2 inhibitory activity, along with the compositions of such compounds, and methods for making and utilizing these innovators. The implications of this work hold potential for therapeutic applications in various medical fields.

Career Highlights: Neil S. Cutshall is currently associated with Omeros Corporation, a company renowned for its focus on developing innovative therapeutics for a range of medical conditions. His extensive patent portfolio exemplifies his commitment to advancing medical science and improving patient outcomes through innovative inventions.

Collaborations: Throughout his career, Cutshall has collaborated with remarkable individuals such as Jennifer Lynn Gage and Thomas L. Little, Jr. These partnerships underscore the collaborative spirit prevalent in the field of biomedical research and innovation, fostering the exchange of ideas that lead to significant advancements.

Conclusion: Neil S. Cutshall's work, particularly with MASP-2 inhibitors, exemplifies the intersection of innovation and practical application in the medical field. As he continues his work at Omeros Corporation, his efforts contribute to the evolving landscape of therapeutic inventions, ultimately benefiting the healthcare community and patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…